These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 11602674)

  • 1. Rational use of in vitro P-glycoprotein assays in drug discovery.
    Polli JW; Wring SA; Humphreys JE; Huang L; Morgan JB; Webster LO; Serabjit-Singh CS
    J Pharmacol Exp Ther; 2001 Nov; 299(2):620-8. PubMed ID: 11602674
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Passive permeability and P-glycoprotein-mediated efflux differentiate central nervous system (CNS) and non-CNS marketed drugs.
    Mahar Doan KM; Humphreys JE; Webster LO; Wring SA; Shampine LJ; Serabjit-Singh CJ; Adkison KK; Polli JW
    J Pharmacol Exp Ther; 2002 Dec; 303(3):1029-37. PubMed ID: 12438524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chalcogenopyrylium dyes as inhibitors/modulators of P-glycoprotein in multidrug-resistant cells.
    Sawada GA; Raub TJ; William Higgins J; Brennan NK; Moore TM; Tombline G; Detty MR
    Bioorg Med Chem; 2008 Nov; 16(22):9745-56. PubMed ID: 18849167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro p-glycoprotein inhibition assays for assessment of clinical drug interaction potential of new drug candidates: a recommendation for probe substrates.
    Rautio J; Humphreys JE; Webster LO; Balakrishnan A; Keogh JP; Kunta JR; Serabjit-Singh CJ; Polli JW
    Drug Metab Dispos; 2006 May; 34(5):786-92. PubMed ID: 16455806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of in vitro P-glycoprotein screening assays: recommendations for their use in drug discovery.
    Schwab D; Fischer H; Tabatabaei A; Poli S; Huwyler J
    J Med Chem; 2003 Apr; 46(9):1716-25. PubMed ID: 12699389
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system.
    Feng B; Mills JB; Davidson RE; Mireles RJ; Janiszewski JS; Troutman MD; de Morais SM
    Drug Metab Dispos; 2008 Feb; 36(2):268-75. PubMed ID: 17962372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional role of P-glycoprotein in limiting intestinal absorption of drugs: contribution of passive permeability to P-glycoprotein mediated efflux transport.
    Varma MV; Sateesh K; Panchagnula R
    Mol Pharm; 2005; 2(1):12-21. PubMed ID: 15804173
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction of cytochrome P450 3A inhibitors with P-glycoprotein.
    Yasuda K; Lan LB; Sanglard D; Furuya K; Schuetz JD; Schuetz EG
    J Pharmacol Exp Ther; 2002 Oct; 303(1):323-32. PubMed ID: 12235267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Several major antiepileptic drugs are substrates for human P-glycoprotein.
    Luna-Tortós C; Fedrowitz M; Löscher W
    Neuropharmacology; 2008 Dec; 55(8):1364-75. PubMed ID: 18824002
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of the permeability and P-glycoprotein efflux of carbamazepine and several derivatives across mouse small intestine by the Ussing chamber technique.
    Fortuna A; Alves G; Falcão A; Soares-da-Silva P
    Epilepsia; 2012 Mar; 53(3):529-38. PubMed ID: 22372629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. First characterization of fish P-glycoprotein (abcb1) substrate specificity using determinations of its ATPase activity and calcein-AM assay with PLHC-1/dox cell line.
    Zaja R; Lončar J; Popovic M; Smital T
    Aquat Toxicol; 2011 May; 103(1-2):53-62. PubMed ID: 21392495
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid excipients Peceol and Gelucire 44/14 decrease P-glycoprotein mediated efflux of rhodamine 123 partially due to modifying P-glycoprotein protein expression within Caco-2 cells.
    Sachs-Barrable K; Thamboo A; Lee SD; Wasan KM
    J Pharm Pharm Sci; 2007; 10(3):319-31. PubMed ID: 17727795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efflux of depsipeptide FK228 (FR901228, NSC-630176) is mediated by P-glycoprotein and multidrug resistance-associated protein 1.
    Xiao JJ; Foraker AB; Swaan PW; Liu S; Huang Y; Dai Z; Chen J; Sadée W; Byrd J; Marcucci G; Chan KK
    J Pharmacol Exp Ther; 2005 Apr; 313(1):268-76. PubMed ID: 15634944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid assessment of p-glycoprotein-drug interactions at the blood-brain barrier.
    Bubik M; Ott M; Mahringer A; Fricker G
    Anal Biochem; 2006 Nov; 358(1):51-8. PubMed ID: 16942742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of 3 assay systems using a common probe substrate, calcein AM, for studying P-gp using a selected set of compounds.
    Szerémy P; Pál A; Méhn D; Tóth B; Fülöp F; Krajcsi P; Herédi-Szabó K
    J Biomol Screen; 2011 Jan; 16(1):112-9. PubMed ID: 21057029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determination of in vitro permeability of drug candidates through a caco-2 cell monolayer by liquid chromatography/tandem mass spectrometry.
    Wang Z; Hop CE; Leung KH; Pang J
    J Mass Spectrom; 2000 Jan; 35(1):71-6. PubMed ID: 10633236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The potential inhibitory effect of antiparasitic drugs and natural products on P-glycoprotein mediated efflux.
    Hayeshi R; Masimirembwa C; Mukanganyama S; Ungell AL
    Eur J Pharm Sci; 2006 Sep; 29(1):70-81. PubMed ID: 16846720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A pharmacophore hypothesis for P-glycoprotein substrate recognition using GRIND-based 3D-QSAR.
    Cianchetta G; Singleton RW; Zhang M; Wildgoose M; Giesing D; Fravolini A; Cruciani G; Vaz RJ
    J Med Chem; 2005 Apr; 48(8):2927-35. PubMed ID: 15828831
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frog intestinal sac as an in vitro method for the assessment of intestinal permeability in humans: Application to carrier transported drugs.
    Franco M; Lopedota A; Trapani A; Cutrignelli A; Meleleo D; Micelli S; Trapani G
    Int J Pharm; 2008 Mar; 352(1-2):182-8. PubMed ID: 18055143
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro and ex vivo evidence for modulation of P-glycoprotein activity by progestins.
    Fröhlich M; Albermann N; Sauer A; Walter-Sack I; Haefeli WE; Weiss J
    Biochem Pharmacol; 2004 Dec; 68(12):2409-16. PubMed ID: 15548387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.